Catheter system for skin passage units

Information

  • Patent Grant
  • 6413244
  • Patent Number
    6,413,244
  • Date Filed
    Monday, December 13, 1999
    25 years ago
  • Date Issued
    Tuesday, July 2, 2002
    22 years ago
Abstract
Catheter system consisting of a sleeve, a catheter and a membrane partially arranged in the sleeve, which can be fixed in a skin passage unit in such a way that the catheter protrudes from the skin passage unit towards the interior of the body, wherein the individual components of the catheter system are inseparably connected to one another.
Description




PRIORITY CLAIM




This application claims priority of Swiss patent application 1997 0727/97, filed Mar. 26, 1997, which hereby fully is incorporated herein by reference.




BACKGROUND OF THE INVENTION




1. Field of the Invention




The invention refers to a catheter system consisting of a sleeve, a catheter and a membrane partially arranged in the sleeve, which can be fixed in a skin passage unit in such a way that the catheter protrudes from the skin passage unit towards the interior of the body, wherein the individual components of the catheter system are inseparably connected to each other.




2. Description of the Related Art




Single and multi-lumen catheters made from extruded plastic and cut to a standard length are known. The catheter tip, arranged at the release site of the drug in the human or animal body, is rounded to such an extent that, as far as possible, the hazard of damaging the vessels or the intestinal skin in the abdominal cavity is avoided. The catheter is purposely produced by the manufacturer in a size exceeding the required length so that the catheter can be shortened to the required length during an operation by cutting away the superfluous part. The catheter end created by the cutting process is subsequently formed into a funnel shape to allow a couple with an infusion set inside a port chamber.




U.S. Pat. No. 5,306,255 and European patent EP-B-0 302 076 describe subcutaneous and percutaneous port bodies. These port bodies serve to connect an infusion hose situated outside of the human or animal body to a port catheter situated inside the human or animal body. External embodiments of such port bodies are sufficiently described in the aforementioned patent specifications and we therefore refer to these specifications at this point.




European patent EP-B-0 398 950 describes the internal design of a port body, the port chamber. The port chamber consists of a membrane chamber with two opposing apertures, a membrane made from a flexible material and arranged between these two apertures, containing a connecting channel in its center between the two apertures of the chamber. One aperture serves to accommodate an external infusion hose while a post catheter is located at the other aperture.




In the known devices, the port catheter is connected to the port chamber in such a way that after one end of the catheter has been formed into a funnel shape, the rounded end of the port catheter tip is pushed through the port until the funnel-shaped part of the port catheter wedges itself in the respective aperture of the port body.




The disadvantage of the known systems is that for the mechanical finishing of the catheter end, resulting in the said funnel shape, a special device is needed whose operation requires prior training. The device must be available in every hospital, resulting in purchasing, maintenance, cleaning and sterilization costs. The finishing of the catheter end also takes up a certain time during the operation. Furthermore, the functionality after the reshaping of the catheter end can only be checked visually in the operating theater.




After having been prepared as specified above, the catheter end must be pushed through the port body into its end position. This requires asserting some force directly on the previously prepared catheter end. As a result the catheter end may be damaged, soiled or incorrectly assembled, causing the drug channel to be blocked. A further disadvantage is that the functionality can only be checked after its installation.




SUMMARY OF THE INVENTION




The invention aims to remedy these disadvantages. The object of the invention is to provide a catheter system for administering drugs that neither requires nor permits a mechanical finishing of a catheter end by the operator, that is simple and secure to handle and allows a quick implantation. The function of the catheter system must also be tested outside of the port and before its implantation.




The invention solves the set task with a catheter system consisting of a sleeve, a catheter and a membrane partially arranged in the sleeve, which can be fixed in a skin passage unit in such a way that the catheter protrudes from the skin passage unit towards the interior of the body, wherein the individual components of the catheter system are inseparably connected to each other.




The invention offers the principle advantages that a mechanical finishing of the catheter by the operator during the operation is neither required nor possible, and that it allows a simple and rapid handling of the catheter system fixing inside the port body.











BRIEF DESCRIPTION OF THE DRAWINGS




A preferred embodiment of the invention is shown in the figures, in which:





FIG. 1

represents a port body; and





FIG. 2

represents a catheter system according to the invention.











DESCRIPTION OF THE PREFERRED EMBODIMENTS




Hereinafter the term “inside” will mean “within the human or animal body” and “outside” will mean “outside of the human or animal body.”




As shown in

FIGS. 1 and 2

, a closing sleeve


4


of a catheter system


1


is inserted into a port body


111


which alternatively may be called a skin passage unit the port body


111


consists of a hollow cylindrical sleeve portion


114


and a radial anchoring plate


113


arranged on the sleeve. The port body


111


contains two opposing apertures


131


,


132


. An aperture


131


facing towards the outside corresponds to the internal diameter of the hollow cylindrical sleeve portion


114


. The second aperture


132


is located at the end of port body


111


and closes off in a conical shape.




As shown in

FIG. 2

, the catheter system


1


consists of a hollow cylindrical closing sleeve


4


, a cylinder-shaped membrane


8


partially arranged in the closing sleeve


4


and a hose-shaped catheter


9


.




The catheter


9


is preferably made from a biocompatible plastic and may be divided into three sections: a catheter head


10


, a hose-shaped interim section


15


and a rounded end section


11


. A continuous drug channel


13


runs through the inside of the catheter


9


.




The outer diameter of the catheter head


10


is larger than that of the hose-shaped interim section


15


. The transition between the catheter head


10


and the interim section


15


is preferably designed as steep.




The inner part of the catheter head


10


is funnel-shaped, ending in the drug channel


13


.




The closing sleeve


4


has a cylindrical structure and contains two opposing apertures


3


,


33


. The aperture


3


, facing towards the outside, is located in the center of a cover


2


, providing the external seal of the closing sleeve


4


. The second aperture


33


, facing towards the inside, corresponds to the internal diameter of the closing sleeve


4


.




The membrane


8


fills the closing sleeve


4


and overlaps the aperture


33


in such a way that it closes off the closing sleeve


4


in a conical shape


14


. The membrane is preferably produced from a flexible plastic such as silicone or polyurethane. The center of the membrane contains a self-closing connecting channel


7


. An inlet aperture


7




a


of the connecting channel


7


, facing towards the outside, is located at the aperture


3


of the cover


2


while an outlet aperture


7




b


of the connecting channel


7


is located inside the membrane. The catheter head


10


is arranged at the outlet opening


7




b


so that the closing sleeve


4


, the membrane


8


and the catheter


9


form one integral unit.




The closing sleeve


4


surrounds the membrane


8


containing the catheter head


10


in such a way that the membrane


8


and the catheter head


10


are centrically held together between the cover and the internal wall


18


of the closing sleeve with a defined initial pressure.




The external casing


19


of the closing sleeve


4


contains up to three closing cams of closing elements so that the closing sleeve


4


and thus the entire catheter system


1


can be installed in a respectively designed cylindrical sleeve portion


114


of port body


111


. The diameter of the cover


2


of the closing sleeve


4


corresponds to the external diameter of the sleeve portion


114


of port body


111


. A closing seal


17


arranged between the cover


2


and the sleeve portion


114


of port body


111


ensures that no dirt or bacteria can enter between the port housing


114


and the closing sleeve


4


.




The closing sleeve


4


is preferably produced from injection-molded plastic. This allows a skin-like color to already be applied to the closing sleeve


4


or at least the cover


2


during manufacture, making the externally visible cover


1


less noticeable.




The requirement for a correct catheter length will be met by producing the catheter


9


in various lengths.




The catheter system


2


according to the invention is installed in a port body


111


in such a way that the catheter


9


is first pushed through the respective opening


132


of the port housing


114


. As soon as the conically shaped section


14


of the membrane


8


pushes against the internal wall of the port housing


114


, the locking cams


5


arranged on the external casing


19


of the closing sleeve


4


are anchored in a respective recess or counter elements of the internal casing of the port sleeve portion


114


of the port body


111


by a slight rotation of the closing sleeve


4


. The hexagonal socket shape of the cover aperture


3


allows the slight rotation of the closing sleeve


4


. Naturally also other key forms are feasible.




To release drugs from a container into a human or animal body, an infusion hose is pushed from the outside through the opening


3


of the lid


2


and through the connecting channel


7


to the catheter head


10


. In order to secure the infusion hose in this connection, the end of the infusion hose can be designed in such a way that it is retained in a respective recess


16


between the membrane


8


and the catheter head


10


.




Once the infusion hose is removed, the aperture


3


can be closed with a cover.



Claims
  • 1. A catheter system for use with a skin passage unit connected to a patient's body, said catheter system comprising:a generally cylindrical sleeve having a substantially continuous cylindrical wall, a first end substantially closed by a cover and an open second end generally opposite the first end, said wall and cover substantially defining an interior space; a membrane material mounted in and generally filling the interior space, said membrane material having an elongated, generally central, self-closing connection channel extending from the cover to the open end of the sleeve; and a catheter having a first end, a second end, a length extending between said ends and a generally central channel, said first end of the catheter mounted in the membrane material, the central channel of the catheter generally aligned with the connection channel of the membrane material, said catheter extending from the sleeve at the open second end, whereby the catheter system can be removably received in the skin passage unit with the catheter protruding from the skin passage unit into the interior of the body.
  • 2. The catheter system according to claim 1, wherein said membrane material is inseparably mounted in the sleeve and the catheter is inseparably mounted in the membrane material.
  • 3. The catheter system according to claim 2, wherein said cover has a generally central aperture, said aperture, connection channel and central channel generally linearly aligned.
  • 4. The catheter system according to claim 1, wherein the skin passage unit comprises a hollow cylindrical sleeve with a first substantially open end and a second end, said hollow cylindrical sleeve having an inside diameter generally corresponding to the outside diameter of the sleeve of the catheter system.
  • 5. The catheter system according to claim 4, wherein a portion of the membrane material extends beyond the catheter system sleeve through the open second end, whereby when said catheter system is installed in the skin passage unit, said portion of the membrane material is adjacent to the second end of the sleeve of the skin passage unit and said cover is adjacent to the first end of the sleeve of the skin passage unit.
  • 6. The catheter system according to claim 1, wherein said membrane material comprises a silicone material, and connects the sleeve and the catheter.
  • 7. A system for administering substances to a body comprising:a skin passage unit comprising a port body comprising a hollow cylindrical sleeve portion and an anchoring plate, said anchoring plate connected to and generally radially arranged around said sleeve portion, said sleeve portion formed by a generally cylindrical wall having an inside surface and an outside surface and having a first substantially open end and a second end; and a catheter system for being removably received in the skin passage unit, said catheter system comprising: a generally cylindrical closing sleeve having a substantially continuous cylindrical wall, a first end substantially closed by a cover portion and an open second end generally opposite the first end, said wall and cover portion substantially defining an interior space; a membrane mounted in and generally filling the interior space, said membrane having an elongated, generally central, self-closing connection channel extending from the cover portion in the direction of the open end of the closing sleeve, a portion of the membrane extending through the open end of the closing sleeve; and a catheter having a first end, a second end, a length extending between said ends and a generally central channel, said first end of the catheter mounted in the membrane, the central channel of the catheter generally aligned with the connection channel of the membrane, said catheter extending from the closing sleeve at the open second end, whereby the catheter system can be removably received in the skin passage unit with the catheter protruding from the skin passage unit into the interior of the body.
  • 8. The system according to claim 7, wherein the membrane material extends from the open second end of the sleeve in a generally conical shape.
  • 9. The system according to claim 8, wherein said conical shape is generally complimentary to the inner end of the skin passage unit, whereby when the catheter system is received in the skin passage unit, the membrane material generally fills and seals the inner end of the skin passage unit.
Priority Claims (1)
Number Date Country Kind
0727/97 Mar 1997 CH
Parent Case Info

This application is a continuation of U.S. patent application Ser. No. 09/048,756, filed Mar. 26, 1998, now issued as U.S. Pat. No. 6,071,265, issued on Jun. 6, 2000, which is hereby incorporated herein by reference.

US Referenced Citations (31)
Number Name Date Kind
1899492 Beebe Feb 1933 A
3783868 Bokros Jan 1974 A
3970089 Saice Jul 1976 A
4436519 O'Neill Mar 1984 A
4475548 Muto Oct 1984 A
4682981 Suzuki et al. Jul 1987 A
4866501 Johnston et al. Sep 1989 A
4880412 Weiss Nov 1989 A
4966588 Rayman et al. Oct 1990 A
5033476 Kasai Jul 1991 A
5092849 Sampson Mar 1992 A
5098397 Svensson et al. Mar 1992 A
5100394 Dudar et al. Mar 1992 A
5104389 Deem et al. Apr 1992 A
5209739 Talalay May 1993 A
5281199 Ensminger et al. Jan 1994 A
5306255 Haindl Apr 1994 A
5324270 Kayan et al. Jun 1994 A
5407434 Gross Apr 1995 A
5429609 Yoon Jul 1995 A
5460616 Weinstein et al. Oct 1995 A
5466230 Davila Nov 1995 A
5514109 Mollenauer et al. May 1996 A
5522803 Teissen-Simony Jun 1996 A
5545143 Fischell Aug 1996 A
5634911 Hermann et al. Jun 1997 A
5634937 Mollenauer et al. Jun 1997 A
5782817 Franzel et al. Jul 1998 A
5800390 Hayakawa et al. Sep 1998 A
5814026 Yoon Sep 1998 A
6010494 Schäfer et al. Jan 2000 A
Foreign Referenced Citations (2)
Number Date Country
B0302076 Apr 1987 EP
B0398950 Jan 1989 EP
Continuations (1)
Number Date Country
Parent 09/048756 Mar 1998 US
Child 09/460144 US